Evidence map›Paper›PMID 37396815›Full record

ArticleJournal of clinical and translational science2023

Approaches for enhancing the informativeness and quality of clinical trials: Innovations and principles for implementing multicenter trials from the Trial Innovation Network.

Karen Lane, Marisha E Palm, Eve Marion, Marie T Kay, Dixie Thompson, Mary Stroud, Helen Boyle, Shannon Hillery, Angeline Nanni, Meghan Hildreth and 15 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Insights from the trial innovation network's initial consultation process.Journal of clinical and translational science · 2025
    Article
  7. Scientia pro bono humani generis: Science for the benefit of humanity.Journal of clinical and translational science · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Karen LaneDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-7529-0714
Marisha E PalmTufts Medical Center, Boston, MA, USA.
Eve MarionDuke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.ORCID https://orcid.org/0000-0002-8559-640X
Marie T KayUniversity of Utah School of Medicine, Salt Lake City, UT, USA.
Dixie ThompsonUniversity of Utah School of Medicine, Salt Lake City, UT, USA.
Mary StroudVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.
Helen BoyleDuke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Shannon HilleryJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Angeline NanniJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Meghan HildrethDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sarah NelsonVanderbilt University Medical Center, Nashville, TN, USA.
Jeri S BurrUniversity of Utah School of Medicine, Salt Lake City, UT, USA.
Terri EdwardsVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.
Lori PooleDuke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Salina P WaddyDivision of Clinical Innovation, National Center for Advancing Translational Sciences, Bethesda, MD, USA.
Sarah E DunsmoreDivision of Clinical Innovation, National Center for Advancing Translational Sciences, Bethesda, MD, USA.
Paul HarrisVanderbilt School of Medicine, Nashville, TN, USA.ORCID https://orcid.org/0000-0002-1744-2011
Consuelo WilkinsDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Gordon R BernardVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.
J Michael DeanUniversity of Utah School of Medicine, Salt Lake City, UT, USA.
Jamie DwyerUniversity of Utah School of Medicine, Salt Lake City, UT, USA.
Daniel K BenjaminDuke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Harry P SelkerInstitute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.ORCID https://orcid.org/0000-0001-5322-7178
Daniel F HanleyAcute Care Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-9536-4258
Daniel E FordInstitute for Clinical and Translational Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-2549-2289

Funding

Utah Trial Innovation CenterU24TR001597 · NCATS · UNIVERSITY OF UTAH · PI DEAN, JONATHAN MICHAEL · 2016 to 2022
$39.6M
Johns Hopkins-Tufts Trial Innovation Center HEAL Pain ERN SupplementU24TR001609 · NCATS · JOHNS HOPKINS UNIVERSITY · PI HANLEY, DANIEL F · 2016 to 2022
$36.3M
Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
NCATS NIH HHS U24 TR001597NCATS NIH HHS U24 TR001609NCATS NIH HHS UL1 TR002538
6 · The paper itself

Abstract

One challenge for multisite clinical trials is ensuring that the conditions of an informative trial are incorporated into all aspects of trial planning and execution. The multicenter model can provide the potential for a more informative environment, but it can also place a trial at risk of becoming uninformative due to lack of rigor, quality control, or effective recruitment, resulting in premature discontinuation and/or non-publication. Key factors that support informativeness are having the right team and resources during study planning and implementation and adequate funding to support performance activities. This communication draws on the experience of the National Center for Advancing Translational Science (NCATS) Trial Innovation Network (TIN) to develop approaches for enhancing the informativeness of clinical trials. We distilled this information into three principles: (1) assemble a diverse team, (2) leverage existing processes and systems, and (3) carefully consider budgets and contracts. The TIN, comprised of NCATS, three Trial Innovation Centers, a Recruitment Innovation Center, and 60+ CTSA Program hubs, provides resources to investigators who are proposing multicenter collaborations. In addition to sharing principles that support the informativeness of clinical trials, we highlight TIN-developed resources relevant for multicenter trial initiation and conduct.

Indexed as

clinical trial budgetsclinical trial resourcesinformative trialsMulticenter trialsstudy planningTrial Innovation Network

Identifiers

PMID37396815
PMCPMC10308427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.